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Abstract 
Previous research has indicated that co-morbid depression is common in adolescents with Chronic 
Fatigue Syndrome (CFS).  
Objectives: We sought to compare the characteristics of depressive symptoms in adolescents with 
CFS to those of healthy controls and illness controls (adolescents with asthma).  
Design: Case control study nested within a prospective clinical cohort.  
Methods: 121 adolescents with CFS who attended an initial assessment at two specialist CFS units 
completed the Children’s Depression Inventory. Their responses were compared to 80 healthy 
controls and 27 adolescents with asthma (illness controls). The clinical cohort of adolescents with 
CFS completed questionnaires at assessment, and those who were seen subsequently for treatment 
at the CFS unit (68%), completed the measures again at their first treatment session.  
Results: CFS participants scored significantly higher on all the depression subscales than participants 
with asthma and healthy controls. Depression score explained 11% of the variance in subsequent 
fatigue, but only 1.9% of the variance in physical functioning. Depression score also explained most 
(68%) of the variance in subsequent depression.  
Conclusion: Depressive symptoms are more prominent in adolescents with CFS than in healthy 
controls or illness controls. Depressive symptoms also appear to remain over time during a 
naturalistic follow-up where no treatment was provided. This highlights the need for further 
research into depression in CFS, including stratifying treatment outcomes by depression status to 
determine what is effective at addressing these symptoms.    
 
Keywords: depression, adolescents, CFS, fatigue, comorbidity 
Introduction  
Chronic Fatigue Syndrome (CFS) affects between 0.1 and 2% of adolescents (Brigden, Loades, 
Abbott, Bond-Kendall, & Crawley, 2017). A diagnosis of CFS is made when an adolescent experiences 
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severe, disabling and unremitting fatigue, lasting for ≥ 3 months, in the absence of another medical 
explanation for it (NICE, 2007). They may experience other symptoms, including pain, headaches, 
nausea, dizziness and problems with attention and concentration (NICE, 2007). Depression seems to 
be particularly prevalent in adolescents with CFS, with as many as one in three experiencing elevated 
depressive symptoms (Bould, Collin, Lewis, Rimes, & Crawley, 2013; Bould, Lewis, Emond, & 
Crawley, 2011; Walford, Nelson, & McCluskey, 1993) or meeting a diagnosis of depression (Garralda 
& Rangel, 2004, 2005; Loades, Rimes, Ali, Lievesley, & Chalder, 2017).   
  
Depression is characterised by low mood, often accompanied by a lack of enjoyment in activities 
(anhedonia), as well as affective, cognitive and physiological symptoms (A.P.A., 2013). To meet a 
diagnosis of major depressive disorder (MDD) on the DSM-5 (A.P.A., 2013), an individual is required 
to have 5 of 9 symptoms, including at least one of the core symptoms of low mood, irritable mood or 
anhedonia, as well as a number of the additional symptoms such as insomnia/hypersomnia, changes 
in appetite, feelings of guilt or worthlessness and psychomotor retardation/agitation. The diagnostic 
criteria specify that these symptoms need to be impacting significantly on the person’s functioning. 
Therefore, MDD is a heterogeneous disorder and the clinical presentation of depression may differ 
from person to person. 
 
The most effective treatment currently available for CFS in adolescents is Cognitive Behaviour 
Therapy (CBT), but a considerable minority of adolescents do not recover, even with treatment 
(Lloyd, Chalder, & Rimes, 2012; Nijhof, Bleijenberg, Uiterwaal, Kimpen, & van de Putte, 2012). CBT 
for CFS entails engaging in making behavioural changes by stabilising and then gradually increasing 
levels of activity, alongside cognitive work to challenge unhelpful thoughts about fatigue and other 
concomitant symptoms, whilst building self-efficacy and shifting the focus of attention away from 
fatigue (Nijhof, Bleijenberg, Uiterwaal, Kimpen, & van de Putte, 2011).  The cognitive model of 
depression purports that people with depression tend to have a negative view of the self, the world 
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and the future, and to think that they are helpless and to view the future in pessimistic terms (Beck, 
1979). They may also lack motivation. Such characteristics of depression may impact on their ability 
to engage in treatment. Therefore, it is possible that those adolescents who have raised depression 
symptoms, as a result of feeling more helpless, hopeless and lacking motivation, are less likely to be 
able to make and sustain the behavioural and cognitive changes required in CBT for CFS. This may 
mean that they are less likely to recover from CFS. CBT is an evidence-based treatment for 
depression in adolescents (Goodyer et al., 2016; NICE, 2015), although the sequence in which 
change techniques are applied, and the specific focus and content of these techniques may be 
different from that in CBT for CFS (Loades & Chalder, 2017). Understanding more about depression 
in adolescents with CFS, including the characteristics of the depressive symptoms and the impact 
these have on outcome could aid our understanding of the maintenance of CFS and of potential 
moderators of outcome.  
 
The aim of the current study was to explore depressive symptoms in adolescents with CFS compared 
to an illness controls (adolescents with asthma) and healthy controls, and to investigate the impact 
of depressive symptoms on outcome in CFS.   
The hypotheses were: 
1) Rates of depressive symptoms will be higher in CFS participants compared to persons with 
asthma and HCs. 
2) Those adolescents with CFS who have elevated depressive symptoms at baseline will have 
less favourable outcomes on fatigue, functioning and subsequent depression at follow-up.  
 
Method: 
 
Participants 
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We recruited 3 groups of participants, who completed questionnaires at baseline. The eligibility 
criterion for all 3 groups was adolescents, age 11-18.  
CFS participants: The additional eligibility criterion for this group was a clinician confirmed diagnosis 
of CFS (NICE, 2007). By definition, those with a primary psychiatric disorder do not meet the 
diagnostic criteria for CFS and are therefore excluded from this group. In total, 207 adolescents 
attended an assessment, of whom 135 were eligible to participate. One hundred and twenty one 
(89.6%) took part (see Table 1 for participant demographics).  
 
Asthma participants: The additional eligibility criteria for this group was being prescribed medication 
for asthma, and having no history of psychiatric disorder.    
 
Healthy controls: The additional eligibility criteria were no history of CFS, asthma, or psychiatric 
disorder.   
 
[insert table 1 about here] 
 
Measures 
Adolescents completed the following measures (see Table 2 for reliability analysis): 
 
Depression – the Children’s Depression Inventory, CDI (Kovacs, 1992) is a self-report measure which 
contains 27 items. The recall period is the last two weeks, and each item is rated on a 3 point scale. 
The CDI is composed of 5 subscales, which are based on the empirically derived factors of negative 
mood, ineffectiveness, anhedonia, low self-esteem and interpersonal problems. A total score for all 
27 items can also be calculated. Both the subscales and the total score were utilised in the analysis. 
Higher scores indicate more depressive symptoms. It is reliable and valid (Kovacs, 1992). 
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Anxiety – the State Trait Anxiety Inventory, STAI (Speilberger, Gorsuch, & Lushene, 1970) is a self-
report measure, composed of 40 items, 20 of which relate to general threat sensitivity, or ‘trait 
anxiety’, and 20 of which relate to anxiety in response to particular threats, or ‘state anxiety’. The 
trait anxiety items are rated with reference to how the person feels generally, and the state anxiety 
items with reference to how the person feels right at the moment when they are completing the 
measure. Each item is rated on a 4 point scale, and the subscale scores are calculated by summing 
the scores for the relevant items. Higher scores indicate higher anxiety levels. Valid and reliability 
have been established previously (Speilberger et al., 1970).  
 
Fatigue – the 11-item Chalder Fatigue Questionnaire, CFQ (Chalder et al., 1993) assesses fatigue 
severity over the past month, encompassing both physical and mental fatigue. Each item is rated on 
a 4 point scale. The Likert method of scoring was used, resulting in a possible maximum score of 33. 
Higher scores indicate higher levels of fatigue. The CFQ has established reliability and validity (M 
Cella & Chalder, 2010). 
 
Physical Functioning – the self-report Short Form 36 physical functioning subscale, SF36PFS (Ware & 
Sherbourne, 1992) has 10 items, which assess the extent to which a respondent is limited by their 
health across a range of activities of daily living. Each item is rated on a 3 point scale (scored 0, 5, or 
10), with a possible maximum score of 100, calculated by summing the scores on each item. Higher 
scores indicate better physical functioning. The SF36 has been previously validated in adolescent 
chronic illness samples e.g. cystic fibrosis (Gee, Abbott, Conway, Etherington, & Webb, 2002). 
 
School and social adjustment – the Work and Social Adjustment Scale (Mundt, Marks, Shear, & 
Greist, 2002) has 5 items which ask about functioning in work, domestic, social and leisure activities 
and close relationships. Each item is rated on a 9 point scale (scored 0-8). The total possible score is 
40, calculated by summing the scores across individual items, with higher scores indicating more 
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impairment. It has established psychometric properties in CFS patients (Matteo Cella, Sharpe, & 
Chalder, 2011). ‘School/college’ was substituted for ‘work’ in this study. 
 
[insert table 2 about here] 
 
Procedure 
CFS patients: A pack of questionnaires and an invitation letter, describing the potential uses of the 
data for research and evaluation, were sent to all those invited to attend an initial assessment 
appointment at 2 specialist CFS units. At the initial assessment, the healthcare professional provided 
the person with an information sheet, sought their consent to participate and collected the 
completed questionnaires. Of the CFS group, 82 (67.8%) participants completed questionnaires 
again at the first treatment appointment attended (although some did not attend this treatment 
appointment due to funding issues, or because they did not require treatment). The interval 
between time 1 (initial assessment) and time 2 (follow-up pre-treatment) was, on average, 3.3 
months (S.D. 2.05, range 0.89-13.60). 
 
[insert table 3 about here] 
 
Asthma patients: Persons who met the inclusion criteria were identified by GP surgeries, who posted 
them an invitation letter and research pack. Baseline measures only were administered to this 
group. 
 
Healthy controls: Potential participants were identified through secondary schools, who sent a letter 
inviting them to participate, and a research pack. The relatives of clinic staff were also invited to 
participate, providing they met the eligibility criteria. Baseline measures only were administered to 
this group. 
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Ethical Approval 
NHS research ethics committee (LREC, ref 08/H0807/107) and the relevant research and 
development department approval was obtained. Furthermore, the local NHS clinical audit 
committee approved the collection and analysis of routine outcomes. 
 
Data Analysis Plan 
SPSS 24.0 was used to conduct the analysis. On any particular scale, where < 25% of the data for a 
participant was missing, the mean of the completed items was substituted in place of the missing 
value(s).  
 
Power and Sample Size: G Power 3.0 was used to calculate sample size required to detect an effect. 
Comparing two independent means, α (sig level) of 0.05 and power of 0.9, 34 participants per group 
would be required to detect a large effect (d = 0.8) with two-tailed tests, and 28 participants per 
group with one tailed tests.   
 
One-way ANOVAs were used to compare the groups on demographic and the variables of interest, 
with post-hoc pairwise comparisons with Bonferroni correction conducted to establish the direction 
of significant findings. As the aim of the current study was to explore possible group differences in 
depression symptoms, we opted not to adjust for multiple testing as this would be overly 
conservative in the context of a preliminary study. 
 
A hierarchical linear regression, informed by the results of the correlations and by theoretical 
assumptions based on previous studies, was used to look at predictors of change over the follow-up 
period in the CFS participants for whom follow-up data was available. Fatigue (CFQ), functioning 
(SF36PFS) and subsequent depression (CDI) were the outcomes of interest. 
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Fatigue/functioning/depression, at baseline and time elapsed between the baseline and the follow-
up, were included as covariates.  
 
Results 
A one-way ANOVA was conducted to compare groups. The groups did not differ significantly on 
mean age but did differ on fatigue, functioning, anxiety and depression (table 3). As predicted, 
participants with CFS scored significantly higher on the CDI than participants with asthma and 
healthy controls. This held true across all 5 CDI subscales.  
 
Those CFS participants followed-up did not differ significantly from those who were not followed up 
(see Table 4), although there was a non-significant trend for those who were followed-up to be 
functioning better at school/socially (SSAS), and to be higher in state anxiety (STAI-S). 
 
[insert tables 3 and 4 about here] 
 
A hierarchical linear regression in which fatigue at time 2 was the outcome of interest was 
conducted. The following variables were entered into the model as covariates: time elapsed 
between time 1 and time 2 (time interval), baseline fatigue, and depression. The results showed that 
a larger time interval and baseline fatigue accounted for 32.8% of the variance in fatigue at time 2. 
Baseline CDI score explained a further 11.2% of the variance (see table 5). For physical functioning at 
time 2, a larger time interval and baseline physical functioning explained 64.7% of the variance. Only 
a further 1.9% was explained by CDI score (see table 5). For depressive symptoms at time 2, time 
interval explained 2.7% of the variance, with baseline CDI score explaining a further 68.3% (see table 
5).  
 
[insert table 5 about here] 
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Discussion 
Adolescents with CFS had more depressive symptoms than adolescents with asthma and healthy 
controls, including higher levels of negative mood, ineffectiveness, anhedonia, low self-esteem and 
interpersonal problems. In the CFS participants, depressive symptoms at time 1 accounted for some 
of the variance in fatigue at time 2, but did not explain much of the variance in subsequent physical 
functioning. Depressive symptoms at time 1 explained most of the variance in subsequent 
depressive symptoms.  
 
Notably, the mean depression score on the CDI in the CFS participants in this study was close to 
recommended cut-offs for identifying depression (Roelofs et al., 2010), suggesting that more than 
one third (45/121) of the sample scored at or above the cut-off of > 16 (Roelofs et al., 2010) for 
depression. This is slightly higher than existing studies, which indicate a prevalence rate of around 
30% (Bould et al., 2013; Garralda & Rangel, 2004, 2005; Loades et al., 2017; Walford et al., 1993). It 
may be that the CDI is better used as a continuous measure of depression rather than a diagnostic 
instrument per se (Matthey & Petrovski, 2002). No normative data is available for the CDI in fatigued 
samples specifically, and given that symptoms of CFS and depression overlap, different cut-off scores 
may be needed (Loades et al., 2017). In the current study, approximately 5% (4/78) of the healthy 
controls and 15% (4/27) of the asthma controls scored above the cut-off for depression. For the 
healthy controls, this is comparable to the expected point prevalence of depression in adolescents, 
which ranges from 3 – 8% (Brent & Maalouf, 2015). Rates of depression in the asthma sample were 
somewhat raised compared to healthy controls but were considerably lower than those in the CFS 
sample.   
 
Several explanations for the connection between CFS and depression in adolescents are possible. First, 
a biological mechanism may explain the high rates of depression in adolescents with CFS; the 
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prevalence of depression in the general population rises substantially in adolescence (Merikangas, 
Nakamura, & Kessler, 2009), as do rates of CFS (Crawley, 2013). It is possible that there is a subtype 
of CFS that is particularly associated with co-morbid depression (Williams, Chalder, Sharpe, & White, 
2017). It follows that  fatigue and depression are potentially linked  at a biological level (Lamers, 
Hickie, & Merikangas, 2013). A second potential explanation for the overlap is behavioural; 
adolescents with CFS have to give up doing things that they enjoy as a result of their illness (Taylor, 
Loades, Brigden, Collin, & Crawley, 2017), which may result in a lack of positive reinforcement, 
resulting in depressive symptoms. Those who are particularly fatigued may have to give up more of 
their activities, compounding this effect. A third possibility is that significant fatigue could result 
from depression, given that fatigue is a symptom of depression (A.P.A., 2013). Longitudinal data in a 
prospective community sample has shown that depression can predict subsequent fatigue (Rimes et 
al., 2007).  
 
Depressive symptoms at the time of presenting to the specialist unit were highly predictive of 
subsequent depressive symptoms. No treatment was systematically offered during this follow-up 
period. It appears that depressive symptoms are likely to require treatment, and do not appear to 
remit spontaneously in adolescents with CFS. However, this data must be interpreted with caution as 
the control groups were not followed up, so it is not clear whether this pattern is specific to CFS or 
extends to adolescents more broadly. We also did not control for factors such as age, gender, pain, 
weight and health-related quality of life; therefore, it is possible that our findings over-estimate the 
impact of depressive symptoms. The current findings suggest that depressive symptoms play a part 
in predicting fatigue outcomes longitudinally.  
 
To further explore the effects of depression in CFS, future studies might assess cognitions such as 
negative thinking errors and self-esteem.  Importantly, previous treatment trials in CFS have not 
been sufficiently powered to detect treatment effects in those with co-morbid depression, so further 
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research is needed to determine the effectiveness of treatment approaches for the group of 
adolescents who have both CFS and co-morbid depression (Loades, Sheils, & Crawley, 2016). It may 
be particularly important to target low mood using treatment approaches such as behavioural 
activation, which aims to gradually reintroduce pleasurable activities.  There is an emerging evidence 
base for behavioural activation in  adolescents with depression (Pass, Lejuez, & Reynolds, 2017).  
 
A thorough assessment of mental health at the time of a CFS diagnosis is important to enable any 
co-morbid distress and co-morbidities to be identified and managed in a timely manner (Loades & 
Chalder, 2017; Loades et al., 2017). As a tool to aid diagnostic assessment, validated measures with 
established cut-off points are required.   
 
Strengths and Limitations 
Participants were consecutively recruited from specialist CFS units, although this setting does limit 
the generalisability of the findings to those presenting to specialist services. The asthma control 
group may also be a biased comparison sample due to the recruitment method, and because despite 
having a chronic illness, they may be relatively well and free of symptoms if their asthma is well-
managed. We did not include a measure of illness impact or health related quality of life, which 
future studies could do. The ethnic origin of the CFS participants and the predominance of females 
(as would be expected from the epidemiology of CFS, Crawley (2014) was different to that of the 
control groups.  
 
In the current study, the CDI was used as a proxy for a confirmed clinical diagnosis of depression. 
However, the CDI has not been psychometrically examined in fatigued samples, nor specifically 
validated for use in adolescents with CFS. Therefore, the assumption that it is a valid and reliable 
measure of depression may be questionable, given the overlap between symptoms of CFS and 
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depression (e.g. fatigue, lack of energy, sleep problems). The follow-up period was variable, although 
we controlled for this in the analysis.   
 
Conclusion 
This study found that adolescents with CFS endorsed more depressive symptoms on all subscales of 
the Children’s Depression Inventory than adolescents with asthma and healthy controls did. This 
included higher levels of negative mood, ineffectiveness, anhedonia, low self-esteem and 
interpersonal problems. In the CFS group, depressive symptoms persisted over time as well. Changes 
in depressive symptoms may account for some of the persistence of fatigue over time but did not 
appear to explain changes in physical functioning. 
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Table 1. Participant demographics  
 CFS participants 
(n=121) 
Asthma participants 
(n=27) 
Healthy Controls 
(n=78) 
Age (mean) 15.0 14.9 14.6 
Gender – N (%) 
Males 35 (28.9) 12 (44.4) 30 (38.5) 
Females 86 (71.1) 15 (55.6) 48 (61.5) 
Ethnicity – N(%) 
White British  86 (71.1) 16 (59.3) 65 (83.3) 
Black British 
Asian/British Asian 
2 (1.7) 1 (3.7) 1 (1.3) 
3 (2.5) 2 (7.4) 2 (2.6) 
Other British/ 
European/White 
25 (20.7) 7 (25.9)  
Other Black/Asian   4 (5.2) 
Mixed race 4 (3.3)  2 (2.6) 
Not stated 4 (3.3) 1 (3.7) 4 (5.1) 
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Table 2. Reliability Analysis (Cronbach’s alpha) for measures 
Measure/Subscale CFS Asthma HC 
CFQ 0.89 0.66 0.82 
SF36PFS 0.91 0.72 0.90 
SSAS 0.81 0.76 0.83 
CDI 0.90 0.85 0.84 
STAI-S 0.93 0.92 0.94 
STAI-T 0.92 0.94 0.93 
CDI – Children’s Depression Inventory, CFQ – Chalder Fatigue Questionnaire, SSAS – School and Social Adjustment Scale, 
SF36PFS – Short form 36 physical functioning subscale, STAI –State-Trait Anxiety Inventory 
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Table 3. Between group comparison on baseline variables 
 Group   
CFS Asthma Healthy controls Group 
difference  
Direction of 
group 
differences 
established in 
post-hoc tests 
Mean (SD) Mean (SD) Mean (SD)   
Age (years)  15.0 (1.7) 15.0 (2.2) 14.6 (1.4) F(2,223)= 
1.57, p=.210 
 
Fatigue (CFQ)  23.2(5.8) 11.9 (2.7) 10.5 (3.8) F(2,222)= 
182.09, 
p<.0001 
 
Physical functioning (SF36PFS)  50.0 (25.1) 88.5 (12.7) 90.3 (17.1) F(2, 214)= 
95.23, p<.0001 
 
School and social functioning (SSAS) 24.6 (8.1) 1.9 (3.7) 1.1 (3.1) F(2, 219) 
=370.31, 
p<.0001 
 
Depressive symptoms (CDI total) 15.7 (8.5) 7.3 (5.8) 5.6 (5.2) F(2, 219) 
=50.73, 
p<.0001 
CFS>asthma=HCs 
CDI Negative Mood subscale 3.5 (2.7) 1.9 (1.8) 1.4 (1.6) F(2, 220)= 
21.62, p<.0001 
CFS>asthma=HCs 
CDI Interpersonal Problems subscale 0.8 (1.0) 0.3 (0.5) 0.6 (0.9) F(2, 220)= 
13.88, p<.0001 
CFS>asthma=HCs 
CDI Ineffectiveness subscale 3.0 (2.0) 1.4 (1.4) 1.1 (1.4) F(2, 213)= 
28.29, p<.0001 
CFS>asthma=HCs 
CDI Anhedonia subscale 6.4 (2.9) 2.2 (2.1) 1.8 (1.9) F(2, 220)= 
89.51, p<.0001 
CFS>asthma=HCs 
CDI Negative Self-esteem subscale 2.1 (2.0) 1.5 (1.3) 1.1 (1.2) F(2, 220)= 
9.12, p<.0001 
CFS>asthma=HCs 
17 
 
State Anxiety (STAI-State) 45.5 (12.6) 34.8 (10.4) 34.8 (11.4) F(2, 222) 
=22.51, 
p<.0001 
CFS>asthma=HCs 
Trait Anxiety (STAI- Trait) 48.0 (11.6) 39.7 (11.4) 37.5 (11.2) F(2, 222) 
=21.71, 
p<.0001 
CFS>asthma=HCs 
CDI – Children’s Depression Inventory, CFQ – Chalder Fatigue Questionnaire, SF36PFS – Short Form 36 Physical Functioning Subscale, SSAS – School and Social Adjustment Scale, STAI – State-
Trait Anxiety Inventory  
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Table 4. Comparison of means between CFS participants with 2 data points and those only seen once 
 CFS 
mean 
(S.D.) – 2 
data 
points 
CFS mean 
(S.D.) – 1 
data point 
Significance 
Tests – t (df) 
Significance 
level (p) 
Mean 
difference 
(95% CI) 
S.E. of 
mean 
difference 
Age 14.94 
(1.77) 
15.15 
(1.57) 
-0.65 (119) .520 -0.22 (-0.44-
0.87) 
0.33 
CFQ 23.17 
(5.89) 
23.26 
(5.60) 
0.09 (118) .932 0.10 (-2.16-
2.35) 
1.14 
SSAS 23.73 
(7.88) 
26.45 
(8.37) 
1.73 (117) .086 2.72 (-0.39-
5.83) 
1.57 
SF-36PFS 51.64 
(24.69) 
46.25 
(25.94) 
-1.06 (111) .294 -5.38 (-15.50-
4.73) 
5.10 
CDI Total 16.38 
(8.84) 
14.29 
(7.56) 
-1.24 (115) .217 -2.09 (-5.42-
1.24) 
1.68 
CDI Negative 
Mood subscale 
3.78 
(2.76) 
3.06  
(2.58) 
-1.35 (116) .181 -0.72 (-1.77-
0.34) 
0.53 
CDI Interpersonal 
Problems 
subscale 
0.88 
(1.01) 
0.77 
(1.03) 
-0.54 (116) .594 -0.11 (-0.50-
0.29) 
0.20 
CDI 
Ineffectiveness 
subscale 
3.08 
(2.07) 
2.74  
(1.95) 
-0.81 (116) .420 -0.34 (-1.16-
0.49) 
0.42 
CDI Anhedonia 
subscale 
6.39 
(2.83) 
6.26 
(3.03) 
-0.22 (116) .825 -0.13 (-1.26-
1.00) 
0.57 
CDI Negative Self-
esteem subscale 
2.21 
(2.06) 
1.83 
(1.82) 
-0.97 (116) .337 -0.38 (-1.15-
0.40) 
0.39 
STAI-S 46.95 
(11.92) 
42.37 
(13.56) 
-1.87 (118) .063 -4.58 (-9.42-
0.26) 
2.44 
STAI-T 48.71 
(11.73) 
46.57 
(11.42) 
-0.94 (118) .352 -2.14 (-6.66-
2.39) 
2.28 
2-tailed tests 
CDI – Children’s Depression Inventory, CFQ – Chalder Fatigue Questionnaire, SF36 – Short for 36 physical functioning 
subscale, SSAS – School and Social Adjustment Scale, STAI – State-Trait Anxiety Inventory   
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Table 5. Hierarchical linear model of predictors of outcome at time 2 
 Unstandardised 
B 
S.E. B Standardised B  T P 
Outcome: Time 2 Fatigue 
Step 1      
     Constant 8.33 2.88  2.89 .005 
     Time between  
      T1 & T2 
-0.25 0.35 -0.08 -0.73 .471 
     T1 fatigue 0.64 0.12 0.57 5.45 <.000 
r2 = 0.328, p < .000 
Step 2      
     Constant 8.38 2.65  3.17 .002 
     Time between  
      T1 & T2 
-0.52 0.33 -0.16 -1.57 .121 
     T1 fatigue 0.47 0.12 0.43 4.02 <.000 
     T1 CDI 0.28 0.08 0.38 3.46 .001 
r2 = 0.439, r2 change = 0.112, p = .001 
 
Outcome: Time 2 Physical Functioning (SF36PFS) 
Step 1 
     Constant 3.35 6.10  0.55 .585 
     Time between  
     T1 &T2 
1.96 0.97 0.16 2.03 .047 
     T1 SF36PFS 0.86 0.08 0.81 10.34 <.000 
r2 = 0.647, p < .000  
Step 2      
     Constant 10.20 7.06  1.45 .154 
     Time between  
     T1 &T2 
2.36 0.97 0.19 2.42 .018 
     T1 SF36PFS 0.83 0.08 0.78 10.08 <.000 
     T1 CDI -0.43 0.23 -0.15 -1.83 .073 
r2 = 0.666, r2 change = 0.019, p = .073 
 
Outcome: Time 2 Depressive symptoms (CDI) 
Step 1      
     Constant 13.53 2.19  6.19 .000 
     Time between  
      T1 & T2 
0.71 0.55 0.16 1.28 .206 
r2 = 0.027, p < .206 
Step 2      
     Constant 3.03 1.50  2.02 .048 
     Time between  
      T1 & T2 
-0.37 0.32 -0.09 -1.15 .254 
     T1 CDI 0.89 0.08 0.86 11.69 <.000 
r2 = 0.710, r2 change = 0.700, p < .000 
B = Beta, CBRQ - Cognitive and Behavioural Responses Questionnaire, CDI – Children’s Depression 
Inventory, CFQ – Chalder Fatigue Questionnaire, SEB – Standard error of Beta,  SF36PFS – Short Form 
36 Physical Functioning Subscale, STAI – State-Trait Anxiety Inventory, SSAS – School and Social 
Adjustment Scale, T1 – Time 1 (initial assessment), T2 – Time 2 (follow-up pre-treatment) 
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